Global diagnostic specialty antibodies market size to expand at 3% CAGR through 2027

The latest research report on ‘global diagnostic specialty antibodies market’, prepared through primary responses, historical data, and public domain data, encompasses an accurate representation of the future growth patterns of the vertical over 2020-2027. It hosts comprehensive information on key factors such as the growth drivers, restraints, and opportunities that are shaping the industry dynamics.

According to industry experts, worldwide diagnostic specialty antibodies industry size was valued approximately USD 19.6 billion in 2019 and is projected to expand at an yearly growth rate of over 3.0% during 2020-2027. Rising burden of infectious diseases, in particular HIV/AIDS, is a major growth propellent for the industry. In fact, the 2018 data by Avert organization cites that nearly 37.9 million individuals were living with HIV, including 1.7 million children, indicating a strong demand for specialty antibodies. Further, increasing R&D expenditure by pharmaceutical and biopharmaceutical companies is the growth propeller of the industry.

In order to provide clear and easily understandable insights on overall market size, the research literature individually assesses each industry segment including type, application, end-user, and geographical scope. Proceeding further, it contains a section dedicated to expounding the competitive landscape, encompassing critical data on leading players, inclusive of their strategies and vision to remain at the top.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/3207981/

For the uninitiated, antibodies, usually known as immunoglobulin, are the part of blood proteins that are produced in response to a certain antigen. These antibodies are effectual and elevate the binding capacity of certain antigens. Technological advancements, particularly in genetic engineering has introduced several antibodies, mostly monoclonal antibodies. These further enhance efficacy and binding capacity to an antigen. Moreover, these antibodies have proven to be valuable in the form of diagnostic tools for assessing and testing various infectious diseases, leading to the rise of diagnostic specialty antibodies market across the globe.

Despite the positive outlook this business sphere, a decline in the demand for diagnostic specialty antibodies has been observed due to concerns regarding capability of antibodies to facilitate precise and smooth operations for regular diagnosis. Moreover, high development cost is another major factor hindering global diagnostic specialty antibodies market expansion.

Regional outlook:

North America is currently the leading contributor to overall diagnostic specialty antibodies industry remuneration. This can be ascribed to spike in cases of infectious ailments and life-threatening diseases in the region. For instance, U.S. Department of Health & Human Services claims that about 21.7 million individuals were living with HIV in 2017, a 2.3 million increase from 2016. In addition, high concentration of market vendors in enhancing the business landscape in the region.

Meanwhile, Asia Pacific diagnostic specialty antibodies market size is slated to grow tremendously over the forecast timeframe. Factors such as rising pharmaceutical and biopharmaceutical expenditure and increasing government initiatives aimed at disease treatment and healthcare infrastructure development in emerging economies like India and China are fostering the regional market growth.

To access a sample pages of this report titled “Global Diagnostic Specialty Antibodies Market Size study, by Type (Monoclonal Antibodies, Polyclonal Antibodies, Others), by Application (Oncology Diagnosis, Hepatitis Diagnosis, Infectious Disease Diagnosis, Others), by End-User (Diagnostic Laboratories, Hospitals) and Regional Forecasts 2020-2027” in detail along with the table of contents, please click the link below:

https://www.marketstudyreport.com/reports/global-diagnostic-specialty-antibodies-market-size-research

Global Diagnostic Specialty Antibodies Market Type Sub-Segments (Revenue, USD billion, 2017-2027)

  • Polyclonal Antibodies
  • Monoclonal Antibodies
  • Others

Global Diagnostic Specialty Antibodies Market Application Sub-Segments (Revenue, USD billion, 2017-2027)

  • Oncology Diagnosis
  • Infectious Disease Diagnosis
  • Hepatitis Diagnosis
  • Others

Global Diagnostic Specialty Antibodies Market End-User Sub-Segments (Revenue, USD billion, 2017-2027)

  • Hospitals
  • Diagnostic Laboratories

Global Diagnostic Specialty Antibodies Market Geographical Fragmentation (Revenue, USD billion, 2017-2027)

North America

  • United States
  • Canada

Europe

  • United Kingdom
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe

Asia Pacific

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • Rest of APAC

Latin America

  • Mexico
  • Brazil

Rest of the World

Global Diagnostic Specialty Antibodies Market Company Profiles (Revenue, USD billion, 2017-2027)

  • Sartorius AG
  • Merck KGaA
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific, Inc.
  • Creative Diagnostics
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Abcam plc
  • Abbott Laboratories
  • F. Hoffmann-La Roche AG

Related Report:

Global Cancer Monoclonal Antibodies Market Size, Regional Forecasts 2020-2027

Global Cancer Monoclonal Antibodies Market is valued at approximately USD 41.3 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 11.3% over the forecast period 2020-2027. Cancer monoclonal antibodies is a type of laboratory-produced molecules which is being serve as substitute antibodies that can improve, restore, or simulate the immune system's raid on cancer cells. They are primarily intended to bind to antigens which are usually more in the amount on the surface of cancer cells than healthy cells. They can be used in the treatment of several types of cancer, including brain cancer, breast cancer, lung cancer, melanoma, and many more, thus accelerating the growth of cancer monoclonal antibodies market around the world.

About US:

Market Study Report, LLC. is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.

Contact Us:

 
Corporate Sales,
Market Study Report LLC
Phone: 1-302-273-0910
Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com

News: http://business-newsupdate.com/

Back to news